|
Synonyms: AGEN-2034 | AGEN2034 | AGEN2034w [6]
Compound class:
Antibody
Comment: Balstilimab (AGEN2034) is an anti-PD-1 checkpoint inhibitor monoclonal antibody. Peptide sequences for the heavy and light chains of balstilimab are claimed in patent US10323091B2 [6], nominally for IgG4 antibody AGEN2034w.
|
| Bioactivity Comments |
| Balstilimab selectively blocks engagement of PD-1 with its ligands, PD-L1 and PD-L2 [6]. |
| Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||